Trial Profile
A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 01 Feb 2024
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications Migraine without aura
- Focus Therapeutic Use
- Acronyms TRIMI
- 01 Feb 2024 Status changed from discontinued to completed.
- 13 Aug 2023 Status changed from not yet recruiting to discontinued.
- 10 Jun 2016 New trial record